Source-grounded facts extracted from CARDINAL HEALTH INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CARDINAL HEALTH INC reported FY26 results: EPS $10.70 to $10.80. Guidance raised.
“Cardinal Health is raising and narrowing its fiscal year 2026 guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $10.70 to $10.80 (+30% to +31% growth).”
CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.
“Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025. Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share (EPS) decreased 20% to $1.69”
CARDINAL HEALTH INC incurred senior notes of $600,000,000 aggregate principal amount of 4.500% Notes due 2030 and $400,000,000 aggregate principal amount of 5.150% N with The Bank of New York Mellon Trust Company, N.A. at 4.500% and 5.150% maturing 2030 and 2035.
“On August 27, 2025, Cardinal Health, Inc. (the “Company”) completed a public offering of $600,000,000 aggregate principal amount of 4.500% Notes due 2030 (the “2030 Notes”) and $400,000,000 aggregate principal amount of 5.150% Notes due 2035 (the “2035 Notes” and, together with the 2030 Notes, the “Notes”).”
Sudhakar Ramakrishna was elected as Director at CARDINAL HEALTH INC.
“On March 7, 2025, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Musslewhite and Sudhakar Ramakrishna to the Board, effective immediately.”
Robert W. Musslewhite was elected as Director at CARDINAL HEALTH INC.
“On March 7, 2025, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Musslewhite and Sudhakar Ramakrishna to the Board, effective immediately.”
Sujatha Chandrasekaran departed as Director at CARDINAL HEALTH INC.
“On September 6, 2024 and September 8, 2024, respectively, Steven K. Barg and Sujatha Chandrasekaran, both members of the Board of Directors (the “Board”) of Cardinal Health, Inc. (the "Company") since 2022, informed the Company that they have decided not to stand for re-election to the Board when their terms expire at the 2024 annual meeting of shareholders.”
Steven K. Barg departed as Director at CARDINAL HEALTH INC.
“On September 6, 2024 and September 8, 2024, respectively, Steven K. Barg and Sujatha Chandrasekaran, both members of the Board of Directors (the “Board”) of Cardinal Health, Inc. (the "Company") since 2022, informed the Company that they have decided not to stand for re-election to the Board when their terms expire at the 2024 annual meeting of shareholders.”
CARDINAL HEALTH INC reported third quarter fiscal year 2024 results: revenue $54.9 billion, net income $258 million, EPS $1.05. Guidance raised.
“Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance • Revenue increased 9% to $54.9 billion • GAAP 1 operating earnings were $367 million; GAAP diluted EPS was $1.05 • Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased 20% to $2.08 • Fiscal year 2024 non-GAAP EPS guidance 2 raised and narrowed to $7.30 to $7.40, from $7.20 to $7.35 • Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.